Literature DB >> 19139737

Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT.

E J Fuchs, L Luznik, J Bolaños-Meade, C B Miller, R A Brodsky, R F Ambinder, R J Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139737      PMCID： PMC3069501          DOI： 10.1038/bmt.2008.416

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Ovarian recovery after stem cell transplantation.

Authors:  J Liu; R Malhotra; J Voltarelli; A B Stracieri; L Oliveira; B P Simoes; E D Ball; E Carrier
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

2.  Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.

Authors:  S Giralt; E Estey; M Albitar; K van Besien; G Rondón; P Anderlini; S O'Brien; I Khouri; J Gajewski; R Mehra; D Claxton; B Andersson; M Beran; D Przepiorka; C Koller; S Kornblau; M Kørbling; M Keating; H Kantarjian; R Champlin
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

3.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

Authors:  P A McSweeney; D Niederwieser; J A Shizuru; B M Sandmaier; A J Molina; D G Maloney; T R Chauncey; T A Gooley; U Hegenbart; R A Nash; J Radich; J L Wagner; S Minor; F R Appelbaum; W I Bensinger; E Bryant; M E Flowers; G E Georges; F C Grumet; H P Kiem; B Torok-Storb; C Yu; K G Blume; R F Storb
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

4.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.

Authors:  N Salooja; R M Szydlo; G Socie; B Rio; R Chatterjee; P Ljungman; M T Van Lint; R Powles; G Jackson; M Hinterberger-Fischer; H J Kolb; J F Apperley
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

5.  Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Authors:  A Carter; L L Robison; L Francisco; D Smith; M Grant; K S Baker; J G Gurney; P B McGlave; D J Weisdorf; S J Forman; S Bhatia
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

6.  Ovarian function following marrow transplantation for aplastic anemia or leukemia.

Authors:  J E Sanders; C D Buckner; D Amos; W Levy; F R Appelbaum; K Doney; R Storb; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

7.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

8.  Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.

Authors:  J E Sanders; J Hawley; W Levy; T Gooley; C D Buckner; H J Deeg; K Doney; R Storb; K Sullivan; R Witherspoon; F R Appelbaum
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

9.  Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Anna Sureda; Stephen Robinson; Carmen Canals; Angelo M Carella; Marc A Boogaerts; Dolores Caballero; Ann E Hunter; Lothar Kanz; Shimon Slavin; Jan J Cornelissen; Martin Gramatzki; Dietger Niederwieser; Nigel H Russell; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2007-12-17       Impact factor: 44.544

10.  Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.

Authors:  Andrew R Rezvani; Barry Storer; Michael Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas Chauncey; Stephen J Forman; Thoralf Lange; Judith Shizuru; Amelia Langston; Michael A Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Journal:  J Clin Oncol       Date:  2007-12-03       Impact factor: 44.544
View more
  2 in total

Review 1.  High-dose cyclophosphamide for graft-versus-host disease prevention.

Authors:  Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Blood and marrow transplantation for sickle cell disease: is less more?

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Blood Rev       Date:  2014-08-27       Impact factor: 8.250
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.